A new arthritis therapy with oxidative burst inducers

PLoS Medicine

Volumn 3, Issue 9, 2006, Pages 1625-1636

  Hultqvist, Malin ^a   Olofssona, Peter ^a,b   Gelderman, Kyra A ^a   Holmbergb, Jens ^a,c   Holmdahl, Rikard ^a  

^a LUND UNIVERSITY   (Sweden)

^b BIOVITRUM AB   (Sweden)

^c Pharmexa AS   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ETANERCEPT; METHOTREXATE; PHYTOL; TUMOR NECROSIS FACTOR ALPHA ANTIBODY; ANTIRHEUMATIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; PRISTANE; REACTIVE OXYGEN METABOLITE; TERPENE;

ACUTE DISEASE; ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTHRITIS; ARTICLE; AUTOIMMUNITY; CHRONIC DISEASE; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG EFFECT; GENETIC POLYMORPHISM; IMMUNOMODULATION; IN VIVO STUDY; INJECTION; NONHUMAN; RAT; RESPIRATORY BURST; STANDARD; T LYMPHOCYTE ACTIVATION; ANIMAL; CELL STRAIN HL 60; HUMAN; LEWIS RAT; METABOLISM; PATHOLOGY; PHYSIOLOGY; RAT STRAIN; RHEUMATOID ARTHRITIS;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIRHEUMATIC AGENTS; ARTHRITIS, EXPERIMENTAL; ARTHRITIS, RHEUMATOID; HL-60 CELLS; HUMANS; PHYTOL; RATS; RATS, INBRED LEW; RATS, MUTANT STRAINS; REACTIVE OXYGEN SPECIES; RESPIRATORY BURST; TERPENES;

EID: 33749037178     PISSN: 15491277     EISSN: 15491676     Source Type: Journal    
DOI: 10.1371/journal.pmed.0030348     Document Type: Article

References (44)

1. Shanahan JC, Moreland LW, Carter RH (2003) Upcoming biologic agents for the treatment of rheumatic diseases. Curr Opin Rheumatol 15: 226-236.
2. Davies JM (1997) Molecular mimicry: Can epitope mimicry induce autoimmune disease? Immunol Cell Biol 75: 113-126.
3. Wanstrat A, Wakeland E (2001) The genetics of complex autoimmune diseases: Non-MHC susceptibility genes. Nat Immunol 2: 802-809.
4. Horikawa Y, Oda N, Cox NJ, Li X, Orho-Melander M, et al. (2000) Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus. Nat Genet 26: 163-175.
5. Lesage S, Zouali H, Cezard JP, Colombel JF, Belaiche J, et al. (2002) CARD15/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease. Am J Hum Genet 70: 845-857.
6. Prokunina L, Castillejo-Lopez C, Oberg F, Gunnarsson I, Berg L, et al. (2002) A regulatory polymorphism in PDCD1 is associated with susceptibility to systemic lupus erythematosus in humans. Nat Genet 32: 666-669.
7. Olofsson P, Holmberg J, Tordsson J, Lu S, Akerstrom B, et al. (2003) Positional identification of Ncf1 as a gene that regulates arthritis severity in rats. Nat Genet 33: 25-32.
8. Babior BM (1999) NADPH oxidase: An update. Blood 93: 1464-1476.
9. Sheppard FR, Kelher MR, Moore EE, McLaughlin NJ, Banerjee A, et al. (2005) Structural organization of the neutrophil NADPH oxidase: Phosphorylation and translocation during priming and activation. J Leukoc Biol 78: 1025-1042.
10. Rosen GM, Pou S, Ramos CL, Cohen MS, Britigan BE (1995) Free radicals and phagocytic cells. FASEB J 9: 200-209.
11. Henrotin YE, Bruckner P, Pujol JP (2003) The role of reactive oxygen species in homeostasis and degradation of cartilage. Osteoarthr Cartil 11: 747-755.
12. Olofsson P, Wernhoff P, Holmberg J, Holmdahl R (2003) Two-loci interaction confirms arthritis-regulating quantitative trait locus on rat chromosome 6. Genomics 82: 652-659.
13. Hua J, Hasebe T, Someya A, Nakamura S, Sugimoto K, et al. (2000) Evaluation of the expression of NADPH oxidase components during maturation of HL-60 cells to neutrophil lineage. J Leukoc Biol 68: 216-224.
14. Dahlgren C, Karlsson A (1999) Respiratory burst in human neutrophils. J Immunol Methods 232: 3-14.
15. Smith BD, Martin GR, Miller EJ, Dorfman A, Swarm R (1975) Nature of the collagen synthesized by a transplanted chondrosarcoma. Arch Biochem Biophys 166: 181-186.
16. Holmdahl R, Carlsen S, Mikulowska A, Vestberg M, Brunsberg U, et al. (1998) Genetic analysis of murine models for rheumatoid arthritis. In: Adolpho KW editor. Human Genome Methods. New York: CRC Press. 215 p.
17. Vowells SJ, Sekhsaria S, Malech HL, Shalit M, Fleisher TA (1995) Flow cytometric analysis of the granulocyte respiratory burst: a comparison study of fluorescent probes. J Immunol Methods 178: 89-97.
18. Buege JA, Aust SD (1978) Microsomal lipid peroxidation. Methods Enzymol 52: 302-310.
19. Saxne T, Heinegard D (1992) Cartilage oligomeric matrix protein: A novel marker of cartilage turnover detectable in synovial fluid and blood [published erratum appears in Br J Rheumatol 1993 Mar;32(3):247]. Br J Rheumatol 31: 583-591.
20. Vingsbo C, Sahlstrand P, Brun JG, Jonsson R, Saxne T, et al. (1996) Pristane-induced arthritis in rats: A new model for rheumatoid arthritis with a chronic disease course influenced by both major histocompatibility complex and non-major histocompatibility complex genes. Am J Pathol 149: 1675-1683.
21. El Benna J, Hayem G, Dang PM, Fay M, Chollet-Martin S, et al. (2002) NADPH oxidase priming and p47phox phosphorylation in neutrophils from synovial fluid of patients with rheumatoid arthritis and spondylarthropathy. Inflammation 26: 273-278.
22. Holmberg J, Tuncel J, Yamada H, Lu S, Olofsson P, et al. (2006) Pristane, a non-antigenic adjuvant, induces MHC class II-restricted, arthritogenic T cells in the rat. J Immunol 176: 1172-1179.
23. Trentham DE, Townes AS, Kang AH (1977) Autoimmunity to type II collagen an experimental model of arthritis. J Exp Med 146: 857-868.
24. Stuart JM, Tomoda K, Yoo TJ, Townes AS, Kang AH (1983) Serum transfer of collagen-induced arthritis. II. Identification and localization of autoantibody to type II collagen in donor and recipient rats. Arthritis Rheum 26: 1237-1244.
25. Vingsbo-Lundberg C, Nordquist N, Olofsson P, Sundvall M, Saxne T, et al. (1998) Genetic control of arthritis onset, severity and chronicity in a model for rheumatoid arthritis in rats. Nat Genet 20: 401-404.
26. Vingsbo C, Jonsson R, Holmdahl R (1995) Avridine-induced arthritis in rats; a T cell-dependent chronic disease influenced both by MHC genes and by non-MHC genes. Clin Exp Immunol 99: 359-363.
27. Drabikova K, Nosal R, Jancinova V, Ciz M, Lojek A (2002) Reactive oxygen metabolite production is inhibited by histamine and H1-antagonist dithiaden in human PMN leukocytes. Free Radic Res 36: 975-980.
28. Brennan FM, Chantry D, Jackson A, Maini R, Feldmann M (1989) Inhibitory effect of TNF alpha antibodies on synovial cell interleukin-1 production in rheumatoid arthritis. Lancet 2: 244-247.
29. Arend WP, Dayer JM (1995) Inhibition of the production and effects of interleukin-1 and tumor necrosis factor alpha in rheumatoid arthritis. Arthritis Rheum 38: 151-160.
30. Choy EH, Panayi GS (2001) Cytokine pathways and joint inflammation in rheumatoid arthritis. N Engl J Med 344: 907-916.
31. Åkerlund K, Erlandsson Harris H, Tracey KJ, Wang H, Fehniger T, et al. (1999) Anti-inflammatory effects of a new tumour necrosis factor-alpha (TNF-alpha) inhibitor (CNI-1493) in collagen-induced arthritis (CIA) in rats. Clin Exp Immunol 115: 32-41.
32. Hultqvist M, Olofsson P, Holmberg J, Backstrom BT, Tordsson J, et al. (2004) Enhanced autoimmunity, arthritis, and encephalomyelitis in mice with a reduced oxidative burst due to a mutation in the Ncf1 gene. Proc Natl Acad Sci U S A 101: 12646-12651.
33. Jackson SH, Gallin JI, Holland SM (1995) The p47phox mouse knock-out model of chronic granulomatous disease. J Exp Med 182: 751-758.
34. Schmielau J, Finn OJ (2001) Activated granulocytes and granulocyte-derived hydrogen peroxide are the underlying mechanism of suppression of T-cell function in advanced cancer patients. Cancer Res 61: 4756-4760.
35. van der Veen RC, Dietlin TA, Karapetian A, Holland SM, Hofman FM (2004) Extra-cellular superoxide promotes T cell expansion through inactivation of nitric oxide. J Neuroimmunol 153: 183-189.
36. Hildeman DA, Mitchell T, Teague TK, Henson P, Day BJ, et al. (1999) Reactive oxygen species regulate activation-induced T cell apoptosis. Immunity 10: 735-744.
37. Gringhuis SI, Papendrecht-van der Voort EA, Leow A, Nivine Levarht EW, Breedveld FC, et al. (2002) Effect of redox balance alterations on cellular localization of LAT and downstream T-cell receptor signaling pathways. Mol Cell Biol 22: 400-411.
38. Angelini G, Gardella S, Ardy M, Ciriolo MR, Filomeni G, et al. (2002) Antigen-presenting dendritic cells provide the reducing extracellular microenvironment required for T lymphocyte activation. Proc Natl Acad Sci U S A 99: 1491-1496.
39. Jackson SH, Devadas S, Kwon J, Pinto LA, Williams MS (2004) T cells express a phagocyte-type NADPH oxidase that is activated after T cell receptor stimulation. Nat Immunol 5: 818-827.
40. Meng TC, Fukada T, Tonks NK (2002) Reversible oxidation and inactivation of protein tyrosine phosphatases in vivo. Mol Cell 9: 387-399.
41. Begovich AB, Carlton VE, Honigberg LA, Schrodi SJ, Chokkalingam AP, et al. (2004) A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis. Am J Hum Genet 75: 330-337.
42. Remans PH, Gringhuis SI, van Laar JM, Sanders ME, Papendrecht-van der Voort EA, et al. (2004) Rap1 signaling is required for suppression of Ras-generated reactive oxygen species and protection against oxidative stress in T lymphocytes. J Immunol 173: 920-931.
43. Bluml S, Kirchberger S, Bochkov VN, Kronke G, Stuhlmeier K, et al. (2005) Oxidized phospholipids negatively regulate dendritic cell maturation induced by TLRs and CD40. J Immunol 175: 501-508.
44. Walton KA, Cole AL, Yeh M, Subbanagounder G, Krutzik SR, et al. (2003) Specific phospholipid oxidation products inhibit ligand activation of toll-like receptors 4 and 2. Arterioscler Thromb Vasc Biol 23: 1197-1203.